Macular Degeneration in Shelton, WA

Macular degeneration is one of the most important conditions we screen for in patients over 50. Unlike cataracts, which cloud your overall vision, macular degeneration specifically attacks the central part of your retina — the macula — which is responsible for the sharp, detailed vision you use to read, recognize faces, and drive. Side vision typically stays intact, but the middle of what you’re looking at can become blurry, distorted, or blank.

The good news: AMD usually progresses slowly, and modern treatments can dramatically slow or even reverse certain types of damage. The catch is that you have to catch it early, and you have to monitor it carefully. That requires technology and consistent follow-up — both of which we provide.

Two types of AMD

Age-related macular degeneration has two main forms, and they behave differently:

Dry AMD (atrophic)

The most common type, accounting for around 85-90% of AMD cases. Dry AMD develops slowly — small yellow deposits called drusen accumulate in the macula, and over time the supporting tissue thins. Vision changes happen gradually, often over many years. There’s no FDA-approved drug therapy to reverse dry AMD, but a specific vitamin formula (AREDS2) can slow progression in patients with intermediate disease, and lifestyle factors matter substantially.

Wet AMD (neovascular)

Less common but more aggressive. In wet AMD, abnormal blood vessels grow under the retina and leak fluid or blood. Vision can change quickly — sometimes over weeks or even days. Wet AMD is treated with anti-VEGF injections given by a retinal specialist; these injections have transformed the prognosis for what used to be a disease that caused severe central vision loss.

Some patients with dry AMD eventually convert to wet AMD — which is why monitoring matters even when things seem stable. Catching the conversion early is what makes treatment most effective.

Symptoms of AMD

AMD usually doesn’t cause pain. The symptoms are all visual, and they affect the central part of vision specifically:

One of the most useful early signs: straight lines start looking bent or wavy. Door frames, the edges of tiles, lined paper. We may give you a simple grid (Amsler grid) to keep at home and check your vision with periodically — if a previously straight grid starts looking distorted, that’s a signal to come in.

Who’s at risk?

AMD is most common in adults over 50, and risk rises steadily with age. Several factors increase your risk:

• Age. The single biggest factor. By age 80, around 30% of people show some signs of AMD.
• Family history. If a parent or sibling has AMD, your risk is significantly higher.
• Smoking. Smokers develop AMD earlier and progress faster. Quitting at any age reduces risk.
• European ancestry. AMD is more common in people of European descent, but it occurs in all populations.
• Cardiovascular disease. High blood pressure, high cholesterol, and atherosclerosis all increase AMD risk.
• Obesity. Independent risk factor.
• Diet low in antioxidants and omega-3s. Diet doesn’t cause AMD, but it appears to influence progression.
• Long-term sunlight exposure without protection. Less established but plausible.

If multiple of these apply to you, especially if you’re over 60, please don’t skip annual eye exams.

How we diagnose and monitor AMD

AMD diagnosis combines a careful look at the macula with advanced imaging that lets us track changes over time at a level of detail that wasn’t possible 15 years ago.

Dilated retinal exam

We dilate your pupils and examine the macula directly under magnification, looking for drusen, pigmentary changes, and signs of bleeding or fluid.

OCT (Optical Coherence Tomography) imaging

This is the workhorse of AMD monitoring. OCT gives us a cross-sectional image of the retina at micron-level resolution — we can see the layers of the macula in detail, measure their thickness, and detect fluid or drusen that wouldn’t be visible to the naked eye. We use OCT both to diagnose AMD and to track its progression year over year. Comparing scans across visits is how we catch wet AMD early, before significant vision loss.

Ultra-widefield retinal imaging

For documentation and comparison. The image becomes a permanent baseline that we can compare against future visits.

Amsler grid testing

A simple, low-tech tool that’s surprisingly powerful. Patients with intermediate or advanced AMD use a grid at home periodically and report any changes — this is one of the earliest warnings of conversion from dry to wet AMD.

How we treat and manage AMD

Our role in AMD care depends on the type and stage:

Early and intermediate dry AMD

We monitor with OCT, recommend AREDS2 vitamins for patients with intermediate disease (the formula has good evidence for slowing progression), and counsel on the lifestyle factors that matter:

• Stop smoking (the single most important modifiable factor)
• Diet rich in dark leafy greens, fish, and colorful vegetables
• UV protection with sunglasses
• Maintain cardiovascular health (blood pressure, cholesterol, weight)

For patients on AREDS2, we’ll review the formula and dosing — the most effective version contains specific amounts of lutein, zeaxanthin, vitamin C, vitamin E, zinc, and copper. Generic “eye vitamins” aren’t the same thing.

Wet AMD

Wet AMD requires treatment by a retinal specialist. The standard treatment is anti-VEGF injections, given in the specialist’s office on a schedule they’ll determine based on your specific situation. These injections have changed the prognosis for wet AMD dramatically — in many cases, vision can be stabilized or even improved.

If we detect signs of wet AMD or conversion from dry to wet, we coordinate referral to a retinal specialist promptly. We continue providing all of your other eye care while you’re being treated by them, and we communicate with their office to make sure your overall plan is coherent.

What you can do right now

• Don’t skip your annual eye exam if you’re over 50, especially if you have any AMD risk factors. Many cases are caught at routine exams before the patient notices anything.
• If you smoke, AMD is one more reason to quit. Smoking is the single most important modifiable risk factor for AMD progression, and the benefit of quitting starts within the first year.
• Eat your vegetables. Dark leafy greens (spinach, kale, collards) and brightly colored vegetables provide lutein and zeaxanthin, which concentrate in the macula.
• Wear sunglasses outdoors. UV protection is cheap, easy, and probably helpful.
• Watch your central vision. If straight lines suddenly look wavy, or you notice a new blurry or dark spot in the center of your vision in either eye — call us right away. Don’t wait for your next scheduled visit.

Insurance coverage

AMD diagnosis and monitoring are billed as medical eye care:

• Medicare and Medicare Advantage — cover the exams, OCT imaging, and follow-up visits, usually with a small copay.
• Apple Health (Washington Medicaid) — covers medical eye visits including AMD monitoring.
• Most major medical plans — Premera, Regence, Blue Cross Blue Shield, Kaiser, UnitedHealthcare, Tricare, Humana, Molina, and others.

If you have a family history of AMD or you’re over 60 and haven’t had a dilated eye exam in a while, please come in. Call us at (360) 427-8324.